TABLE 2.

Relative AAV promoter strength^a

Time interval (h) during infection	P40:P5/19b	P19:P5c
3–5	4.79	1.80
4–6	4.52	2.65
5–7	4.14	2.66
6–8	4.14	2.94
7–9	4.89	2.62
8–10	4.65	2.42
9–11	4.29	2.85
10–12	4.93	2.85
Mean ± SD	4.54 ± 0.32	2.60 ± 0.36

^aDerived from the slopes of the curves in Fig. 4D and E over short (3-h) time intervals where AAV RNAs were shown to be stable. 

^bThe rate (increase/time) of P40 accumulation divided by the rate of P5/19 accumulation (both taken from Fig. 4D and E) for each time interval shown; the RP probe was used. 

^cThe rate (increase/time) of P19 accumulation divided by the rate of P5 accumulation (both taken from Fig. 4D and E) for each time interval shown; the SB probe was used.